ABSTRACT
INTRODUCTION
Dicistronic vectors recently have been developed that increase the frequency of heterologous gene expression in transfected cells (7, 10, 11, 13, 14) . In these vectors, a single promoter drives the transcription of tandem cDNAs, and translation of the 3 ′ -positioned cDNA (typically a selectable marker) is directed by an internal ribosomal entry site (IRES) from encephalomyocarditis virus (EMCV) (5) . EMCV possesses an uncapped RNA strand including a 600-nucleotide (nt) IRES with a 5 ′ untranslated region (UTR) that initiates translation by means of a cap-independent mechanism (5) . When positioned between heterologous cDNAs, this element can mediate the translation of 3 ′ -positioned constructs (7, 9) , thereby coupling the expression to 5 ′ -inserted cDNAs (7, 11, 14) . This provides an advantage over co-transfected or dual-promoter vectors in which expression is often uncoupled (7, 8) . Among IRES-containing dicistronic vectors, several distinct 3 ′ marker cassettes exist, including: pCIN (14) and pMK (11) vectors include neomycin phosphotransferase, the tetracycline inducible vector pTETi β geo (10) encodes a lacZ -neomycin phosphotransferase fusion gene and the retroviral vector pED4 (7) contains a 3 ′ -positioned dihydrofolate reductase (DHFR) cassette. Tet-inducible vectors such as pTETi β geo, however, require extended induction and incubations with fluorescein di-β -D -galactopyranoside, while pED4 requires the use of DHFR -/-target cells. Dicistronic vectors encoding green fluorescent protein (GFP) (e.g., pTR-DC/GFP; Reference 13) allow selection by fluorescence-activated cell sorting (FACS), but in at least certain systems, clones stably expressing S65T GFP can be inactivated by rearrangement or mutation (3) .
For the selection of tranfected cells, immunomagnetic methods (i.e., magnetic cell sorting [MACS]) using ferrit particle-coupled antibodies against cell-surface markers provide a direct approach (12, 17) . For MACS, pSR α MSV-TKCD8 and pMT-IRES-CD4 vectors have been previously developed. However, the pSR α MSV-TKCD8 vector is not dicistronic (6) , and in studies of stably transfected cells, pMT-IRES-CD4 was co-transfected with a neomycin-encoding plasmid; it is unclear whether this vector alone can be used to efficiently select stably transfected lines (18) . In addition, the use of a full-length CD4 cDNA in this vector is potentially complicating. To provide for the selection of stably transfected cells co-expressing marker and heterologous cDNAs at high frequencies, a vector presently has been developed in which a cytomegalovirus (CMV) promoter drives ex -Sho r t Technical Repo r t s pression of dicistronic transcripts that contain a centrally positioned EMCV IRES and a 3 ′ cassette encoding a truncated form of human CD4 gene (1) . To test the utility of this vector, a luciferase reporter gene was inserted, and this construct was electrotransfected into myeloid FDCW2 cells (16) . Cells stably expressing CD4t were isolated by either MACS or FACS. Analyses of marker and reporter expression show that this pIRES-CD4t vector provides for the direct and efficient isolation of transfected cells and stably drives the coupled expression of inserted heterologous cDNAs.
MATERIALS AND METHODS

Dicistronic Expression Vectors
pIRES-CD4t was constructed by replacing the neomycin phosphotransferase gene in pIRES1 neo(CLON-TECH Laboratories, Palo Alto, CA, USA) with a cDNA encoding the extracellular and transmembrane domains of human CD4 (1). This cDNA was excised from pMACS 4 (Miltenyi Biotec, Bergisch Gladbach, Germany) using Eco RI (site located 81 nt upstream from the AUG start codon) and Pst I (site located 12 nt 3 ′ to a stop codon positioned five amino acids after the transmembrane domain) and was cloned (1363-bp fragment) into pBluescript ® KS(+) (Stratagene, Palo Alto, CA, USA). pBS-CD4t then was digested with Eco RI, blunt-ended using the Klenow fragment of DNA polymerase I (New England Biolabs, Beverly, MA, USA) and digested with Xba I to yield a 5 ′ -blunted, 3 ′ Xba I fragment. pIRES1 neowas digested with Sma I and Xba I to excise the neomycin phosphotransferase gene, and the above CD4t cDNA fragment was ligated into these sites to yield pIRES-CD4t. pIRES-CD4t-luc was constructed as follows. A luciferase cDNA was isolated from pSP-luc + (Promega, Madison, WI, USA) by digestion with Hin dIII, blunt-ending with the Klenow fragment of DNA polymerase I and digestion with Eco RI. This 1669-bp fragment then was cloned into pIRES-CD4t at Eco RV and Eco RI sites to yield pIRESCD4t-luc .
Cell Culture, Electrotransfections and MACS Selection
FDCW2 cells were maintained at 37°C, 5% CO 2 in OPTI -MEM™I medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 8% fetal bovine serum (FBS) and 8% Wehi3B-cell-conditioned medium (W3CM) as a source of Interleukin-3 (IL-3). Electrotransfections were performed as detailed previously (16) . Following electrotransfections, 1 × 10 7 expanded cells were subjected to selection using anti-CD4 conjugated microbeads (Miltenyi Biotec) . Cells were collected by centrifugation (800 ×gfor 10 min) and were resuspended in 10 mL of degassed phosphate-buffered saline (PBS) (2.7 mM KCl, 140 mM NaCl, 1.5 mM KH 2 PO 4 , 8 mM Na 2 HPO 4 . 7H 2 O, pH 7.2) containing 5 mM Na 2 EDTA. Cells then were collected, resuspended in 320 µ L of PBS, 5 mM Na 2 EDTA, 0.5% 684BioTechniques
Vol. 26, No. 4 (1999) Figure 1 . pIRES-CD4t and pIRES-CD4t-luc dicistronic expression vectors. pIRES-CD4t was constructed by cloning a CD4t cDNA from pBS-CD4t (see Materials and Methods) into pIRES neo(originally described as pCIN4; Reference 3). Contained in pIRES-CD4t are a CMV major immediate early enhancer/promoter (CMV P/E), a synthetic intron known to enhance mRNA stability (IVS), an MCS, a 585-bp EMCV IRES, the above 3 ′ -positioned CD4t cDNA and a polyadenylation signal sequence from a bovine growth hormone cDNA (omitted in this schematic are an ampicillin-resistance gene and an E. coli origin of replication). In CD4t, the start codon is located 102 nt downstream of AUG 10 within the EMCV IRES. pIRES-CD4-lucwas constructed by cloning a luciferase cDNA from pSP-luc + into Eco RV and Eco RI sites within the MCS of pIRES-CD4t. BSA and were incubated with 80 µ L of MACSelect 4 Microbeads (Miltenyi Biotec) for 15 min at 10°C. The total sample volume then was adjusted to 2 mL using PBS, 5 mM Na 2 EDTA, 0.5% BSA and was loaded onto an MS + /RS + column within the magnetic field of a miniMACS Separation Unit (Miltenyi Biotec) . The flow-through volume was collected and was reapplied to the column. The column then was washed 6 × with 500 µ L of PBS, 5 mM Na 2 EDTA and 0.5% BSA. Bound cells were eluted in 1 mL of PBS, 5 mM Na 2 EDTA and 0.5% BSA, collected, resuspended in 3 mL of OPTI -MEM I medium, 8% FBS, 8% W3CM and cultured for 2 days in a 6-well Falcon ® tissue culture plate (Becton Dickinson Labware, Bedford, MA, USA) in the presence of penicillin (100 U/mL), streptomycin (100 µ g/mL) and amphotericin B (0.25 µ g/mL).
Flow Cytometry, FACS and Luciferase Assays
In assays of CD4t expression, cells were labeled with a phycoerythrin (PE)-conjugated anti-CD4 monoclonal antibody (MAb) (PE-RPA-T4; PharMingen, San Diego, CA, USA) and were analyzed by flow cytometry. Specifically, cells (1 ×10 7 ) were incubated at 4°C for 10 min, collected by centrifugation at 200 × gfor 10 min and washed at 4°C in PBS and 0.05% BSA. Cells then were collected at 1000 × g for 4°C for 60 min. Cells then were diluted with 1 mL of PBS, 0.05% BSA, collected (1000 ×gfor 5 min), resuspended in 500 µ L of PBS, 0.05% BSA and held at 4°C. Flow cytometric analyses were performed using an EPICS ® XL system (15-mW argon-ion laser, 488 nm) and Coulter ® XL-2 software (both from Beckman Coulter, Fullerton, CA, USA). PE-conjugated calibration particles (Catalog No. RCP 30-5; Spherotech, Libertyville, IL, USA) were used to calculate the average number of PE-RPA-T4 molecules on the surface of transfected cells. FACS was performed using an EPICS Elite system (15-mW argon-ion laser, 488 nm; Beckman Coulter), and PE-positive vs. -negative populations were gated and collected. Each population was washed in OPTI -MEM I medium, cultured for 24 h in OPTI -MEM I medium, 8% FBS, 8% W3CM supplemented with penicillin (200 U/mL), streptomycin (200 µ g/mL) and amphotericin B (0.5 µ g/mL) (Sigma) and expanded. In luciferase assays, cell lysates were prepared by collecting cells (3 ×10 6 ) at 200 × gfor 10 min, washing cells in 10 mL of PBS and preparing lysates in 60 µ L of 1% Triton ® X-100, 2 mM 1,2-diaminocyclohexane-N , N , N ′ , N ′ -tetraacetic acid, 2 mM dithiothreitol (DTT), 10% glycerol, 25 mM Tris-phosphate, pH 7.8 (Catalog No. E153A; Promega). To ensure lysis, samples were mixed by vortex mixing for 15 min at 23°C, and cleared lysates were prepared by centrifugation at 8000 × g for 10 min. In luciferase assays, 20 µ L of lysate were added to 100 µ L of 20 mM tricine, 1.07 mM (MgCO 3 ) 4 Mg(OH) 2 . 5H 2 0, 2.67 mM MgSO 4 , 0.1 mM EDTA, 33.3 mM DTT, 270 µ M coenzyme A, 470 µ M luciferin, 530 µ M ATP (Catalog No. E1483; Promega). To control for possible differences in cell number or lysis, lysates were assayed for protein content (BCA Protein Assay; Pierce Chemical, Rockford, IL, USA), and values were used to normalize luciferase activities.
RESULTS
To test for coupled expression of CD4t and a cDNA insert, a luciferase gene was cloned into pIRES-CD4t, and this construct (Figure 1 ) was transfected into FDCW2 cells. By intent, FDCW2 cells were used based on their low transfection efficiency and the associated challenge in retrieving derived cell lines that express transfected cDNAs at useful, uniform levels. Transfected cells were subjected to four rounds of MACS (populations MACS 1-4) and were assayed for CD4t expression (Figure 2 ). Three rounds of MACS yielded cells expressing CD4t at high frequencies (91% PE-RPA-T4 antibody positive), while a fourth round of MACS only slightly increased frequencies of CD4t-positive cells (96%).
Absolute levels of CD4t expression were estimated using PE-conjugated calibration particles. In MACS 4 cells, an average of 34 000 PE-RPA-T4 antibodies were bound per cell, and CD4t expression is estimated at 17 000 molecules per cell. This indicates efficient translation of CD4t from pIRES-CD4t-lucand predicts that selected cells should uniformly express linked 5 ′ cDNAs at useful levels. To test this, luciferase expression was assayed in polyclonal FDCW2-pIRES-CD4t-luc cells and in sublines isolated by dilution cloning (16) of MACS 4 cells. Upon MACS retrieval, luciferase activity in polyclonal populations increased markedly (Figure 2 ). In addition, luciferase expression in each of ten clonal sub-lines was comparable to that in MACS 4 cells (Table 1) . This result confirms tightly coupled expression of marker and inserted cDNAs. To test stability of expression, luciferase activity also was monitored over a test period of three months. Activity remained high in all cells tested in the absence of further selection (Table 1) .
Finally, MACS and FACS were compared directly as methods for isolating stably transfected cells. Here, a MACS 2 population of FDCW2-pIRES-CD4t-luccells was used based on the presence of low but detectable frequencies of CD4t-expressing cells (approximately 1%). FACS was applied, and two gated populations of cells (FACS-positive and FACS-negative cells) were recovered. Cells from each population were expanded and analyzed for CD4t and luciferase expression (Figure 3) . FACS increased frequencies of CD4t-positive cells to 67%, whereas MACS (performed in parallel) increased frequencies to 87%. In addition, FACS-positive and MACS 3 populations each expressed significantly increased levels of luciferase activity compared to the FACS-negative and MACS 2 populations (16.7 and 7.7 vs. 0.5 and 0.4 relative light units [RLU], respectively). Therefore, MACS was at least as efficient as FACS in selecting transfected CD4t-positive cells.
DISCUSSION
pIRES-CD4t has been developed as an expression vector that combines the advantages of dicistronic expression and MACS. Two features that merit discussion are the choice of CD4t as a marker and the nature of the IRES used to direct translation. Studies of CD4 in human immunodeficiency virus (HIV) infection have led to the development of MAbs with high specificities and affinities as conjugated forms for direct use in MACS and FACS (4) . Thus, cells transfected with pIRES-CD4t can be efficiently retrieved and analyzed quantitatively using commercially available reagents. The α CD4-conjugated, ferritdextran microbeads used in the present study, in fact, have been applied to isolate CD4+ T-cells from peripheral blood lymphocytes in clinical applications (19) . Since CD4 expression is restricted largely to developing thymocytes and major histocompatibility complex (MHC) II-restricted mature T-lymphocytes (2), this marker can be used in a wide variety of cells and cell lines.
IRES from EMCV was used since eukaryotic initiation factors eIF-2/2B bind to this IRES with high affinity (15) , and because this IRES is perhaps best characterized (7, 9) . In addition, in pIRES-CD4t, this IRES is engineered to repress the expression of inappropriate fusion proteins, and to attenuate 3 ′ cassette translation (the predominant initiation site AUG-11 is deleted, and a 94-bp spacer cassette shifts translational initiation to the Met 1 of CD4t; Reference 14) . This modification also attenuates translation of 3 ′ cassettes within dicistronic transcripts and favors highlevel translation of 5 ′ -positioned cDNAs (14) . Thus, pIRES-CD4t is a unique dicistronic vector that provides for the coupled expression of heterologous cDNAs and a 3 ′ -positioned CD4 marker cassette. Transfected cells can be isolated directly by either MACS or FACS, and coordinate expression provides for sustained high frequencies of heterologous cDNA expression in selected cells.
